摘要
Leucine zipper和sterile-α motif kinase (Zak)是混合谱系激酶家族的一个成员(MLKs),它是不同的生理疾病的新靶点,包括心肌肥厚和心肌纤维化,炎症和癌症。然而,其生物功能和小分子抑制剂的进展是有限的。只有多激酶抑制剂被报道可以非选择性结合各种Zak还有许多潜在物。在此,我们提供了一个关于生物学功能和Zak小分子抑制剂最新的概述。
关键词: ZAK
Current Medicinal Chemistry
Title:Leucine-zipper and Sterile-α Motif Kinase (ZAK): A Potential Target for Drug Discovery
Volume: 23 Issue: 33
Author(s): Yu Chang, Qingwen Zhang, Zhengqiu Li, Ke Ding, Xiaoyun Lu
Affiliation:
关键词: ZAK
摘要: Leucine-zipper and sterile-α motif kinase (ZAK) is a member of mixed-lineage kinase family (MLKs), which is considered as a new potential target for different physiological disorders, including myocardial hypertrophy and cardiac fibrosis, inflammation and cancer. However, the progress on its biological functions and small molecule inhibitors is limited. Only several multi-kinases inhibitors are reported to non-selectively bind with ZAK with various potencies. Herein, we provide an updated overview on the biological functions and small molecular inhibitors of ZAKs.
Export Options
About this article
Cite this article as:
Yu Chang, Qingwen Zhang, Zhengqiu Li, Ke Ding, Xiaoyun Lu , Leucine-zipper and Sterile-α Motif Kinase (ZAK): A Potential Target for Drug Discovery, Current Medicinal Chemistry 2016; 23 (33) . https://dx.doi.org/10.2174/0929867323666160920104121
DOI https://dx.doi.org/10.2174/0929867323666160920104121 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Assessing Myocardial Metabolism with Hybrid PET Imaging: Instrumentation, Concepts, and Workflows
Current Pharmaceutical Design Editorial (Thematic Issue: Drug Delivery Design for Regenerative Medicine)
Current Pharmaceutical Design Targeting MDM2 and MDMX in Retinoblastoma
Current Cancer Drug Targets Nutraceuticals - An Emerging Era in the Treatment and Prevention of Cardiovascular Diseases
Current Pharmaceutical Biotechnology Anti-HER2 Therapy in Elderly Breast Cancer Patients
Reviews on Recent Clinical Trials The Effects of Olprinone, a Phosphodiesterase 3 Inhibitor, on Systemic and Cerebral Circulation
Current Vascular Pharmacology PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
Current Medicinal Chemistry The Histone Deacetylase Inhibitor, MS-275 (Entinostat), Downregulates c-FLIP, Sensitizes Osteosarcoma Cells to FasL, and Induces the Regression of Osteosarcoma Lung Metastases
Current Cancer Drug Targets HIV-1 Vectors: Fulfillment of Expectations, Further Advancements, and Still A Way To Go
Current HIV Research Three Dimensional Echocardiography: Recent Trends in Segmen tation Methods
Current Medical Imaging Severe Psychiatric Disorders in Mid-Life and Risk of Dementia in Late- Life (Age 65-84 Years): A Population Based Case-Control Study
Current Alzheimer Research Design, Synthesis, and Structure-Activity Relationship Study of Peroxisome Proliferator-Activated Receptor (PPAR) δ-Selective Ligands
Current Medicinal Chemistry Genetics of Hypertrophic and Dilated Cardiomyopathy
Current Pharmaceutical Biotechnology Nitric Oxide Synthases and Their Natural Inhibitors
Current Enzyme Inhibition Serpinins: Role in Granule Biogenesis, Inhibition of Cell Death and Cardiac Function
Current Medicinal Chemistry The Relationship Between Oncogene Expression and Clinical Outcome in Endometrial Carcinoma
Current Cancer Drug Targets The Mechanism of Carvedilol in Experimental Viral Myocarditis
Current Pharmaceutical Design The Synthetic Cannabinoids Phenomenon
Current Pharmaceutical Design Does Angiotensin Converting Enzyme Inhibitor Protect the Heart in Cardiac Surgery? From Laboratory to Operating Room: Clinical Application of Experimental Study
Current Pharmaceutical Design Pituitary Dysfunction as a Cause of Cardiovascular Disease
Current Pharmaceutical Design